Valsts: Lielbritānija
Valoda: angļu
Klimata pārmaiņas: MHRA (Medicines & Healthcare Products Regulatory Agency)
Enalapril maleate
Milpharm Ltd
C09AA02
Enalapril maleate
5mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02050501; GTIN: 5060035110254
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What is Enalapril maleate Tablet and what is it used for. 2. What you need to know before you take Enalapril maleate Tablets 3. How to take Enalapril maleate Tablet 4. Possible side effects 5. How to store Enalapril maleate Tablet 6. Contents of the pack and other information 1. WHAT ENALAPRIL MALEATE TABLETS ARE AND WHAT THEY ARE USED FOR Enalapril maleate belongs to the class of medicines called Angiotensin converting enzyme inhibitors (ACE inhibitors). It works by causing blood vessels to relax, lowering blood pressure and increasing the supply of blood and oxygen to the heart. Enalapril maleate Tablets are used • To treat high blood pressure (hypertension) • To treat heart failure (weakening of heart function). It can lower the need to go to hospital and can help some patients live longer. • To prevent signs of heart failure. The signs include shortness of breath, tiredness after light physical activity such as walking, or swelling of the ankles and feet. This medicine works by widening your blood vessels. This lowers your blood pressure. The medicine usually starts to work within an hour, and the effect lasts for at least 24 hours. Some people will require several weeks of treatment until the best effect on your blood pressure is seen. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ENALAPRIL MALEATE TABLETS DO NOT TAKE ENALAPRIL MALEATE TABLETS • If you are allergic (hypersensitive) to enalapril maleate, any of the other ingredients in these tablets or other ACE inhibitors (see Section 6 Izlasiet visu dokumentu
OBJECT 1 ENALAPRIL 5MG TABLETS Summary of Product Characteristics Updated 25-Mar-2020 | Aurobindo Pharma - Milpharm Ltd. • 1. Name of the medicinal product • 2. Qualitative and quantitative composition • 3. Pharmaceutical form • 4. Clinical particulars • 4.1 Therapeutic indications • 4.2 Posology and method of administration • 4.3 Contraindications • 4.4 Special warnings and precautions for use • 4.5 Interaction with other medicinal products and other forms of interaction • 4.6 Fertility, pregnancy and lactation • 4.7 Effects on ability to drive and use machines • 4.8 Undesirable effects • 4.9 Overdose • 5. Pharmacological properties • 5.1 Pharmacodynamic properties • 5.2 Pharmacokinetic properties • 5.3 Preclinical safety data • 6. Pharmaceutical particulars • 6.1 List of excipients • 6.2 Incompatibilities • 6.3 Shelf life • 6.4 Special precautions for storage • 6.5 Nature and contents of container • 6.6 Special precautions for disposal and other handling • 7. Marketing authorisation holder • 8. Marketing authorisation number(s) • 9. Date of first authorisation/renewal of the authorisation • 10. Date of revision of the text 1. Name of the medicinal product Enalapril Maleate 5mg tablets 2. Qualitative and quantitative composition Each tablet contains 5 mg Enalapril maleate. Excipient: each tablet contains 79.8 mg of lactose monohydrate. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Tablets White to off-white round flat bevelled edged tablets marked with “5” on one side and break line on the other. 4. Clinical particulars 4.1 Therapeutic indications • Treatment of hypertension • Treatment of symptomatic heart failure • Prevention of symptomatic heart failure in patients with asymptomatic left ventricular dysfunction (ejection fraction ≤35%) (See section 5.1). 4.2 Posology and method of administration Posology Food does not interfere with the absorption of enalapril. The dose should be individualized according to patient pr Izlasiet visu dokumentu